Consonance Capital Partners has closed Consonance Private Equity III at its $1.35 billion hard cap, about four months after the fund went to market. The fund was heavily oversubscribed and drew commitments from existing limited partners and a group of new investors, including endowments, foundations, pension plans and financial institutions from around the world. Consonance reported the final close on Oct. 9.
Consonance invests in lower and middle-market U.S. healthcare companies through growth equity, leveraged buyouts, carve-outs, recapitalizations and special situations. The firm backs businesses that improve efficiency, contain costs and deliver quality care. Fund III will follow the same strategy as the firm’s earlier funds. The New York firm previously invested out of Consonance Private Equity II.
Read the full intelligence on AlphaMaven
Subscribe to unlock the AI-extracted Key Takeaways, the News Summary that synthesizes this story with related coverage, and the full alternative-investment intelligence platform — $99/mo, no contract, cancel anytime.
